Bioray Biotech Co

Bioray Biotech Co Assets per Share

The Total Assets per Share of Bioray Biotech Co (7561.TWO) as of Nov 2, 2026 is 17.83 TWD. In the previous year, Total Assets per Share was 18.07 TWD — a change of -1.30% (lower).

Assets per Share

17.83TWD

YoY

-1.30%

Last updated:

Total Assets per Share of Bioray Biotech Co is 2025 17.83 TWD. Total Assets per Share of Bioray Biotech Co was 2024 18.07 TWD. It decreases by -1.30% lower compared to the previous year.

The Bioray Biotech Co Assets per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Assets per Share
Date
Assets per Share
Jan 1, 2018
15.65 TWD
Jan 1, 2019
16.61 TWD
Jan 1, 2020
15.81 TWD
Jan 1, 2021
15.49 TWD
Jan 1, 2022
19.89 TWD
Jan 1, 2023
18.03 TWD
Jan 1, 2024
18.07 TWD
Jan 1, 2025
17.83 TWD
The Bioray Biotech Co Assets per Share history
YEARAssets per ShareYoY
17.83TWD-1.30%
18.07TWD+0.18%
18.03TWD-9.35%
19.89TWD+28.41%
15.49TWD-2.02%
15.81TWD-4.79%
16.61TWD+6.10%
15.65TWD+59.19%
9.83TWD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Bioray Biotech Co Stock analysis

What does Bioray Biotech Co do? BioRay Biotech Co., Ltd. generates revenue through its biological health products, functional medical testing services, and cell storage and preparation offerings. The company sells personalized probiotics, anti-allergic and intestinal probiotics, diabetes probiotics, female urinary tract products, and anti-arthritis probiotics. Functional medical testing includes personalized bacteria, personalized fungi, intestinal normal bacteria, quantitative magnesium detection in red blood cells, metabolic gene polymorphism analysis, and lymphocyte grouping. Cell storage services feature stem cell storage, immune cell storage, and cytokine induced killer (CIK) immune cell preparations. The primary customers for these products and services are individuals seeking personalized health solutions, including those managing chronic conditions like diabetes or arthritis. The company targets health-conscious consumers and medical professionals requiring specialized testing and cell-based therapies. BioRay Biotech focuses on delivering tailored health and medical services through its integrated product and service portfolio. Revenue streams are derived from direct sales of health products, testing service fees, and cell storage contracts. The business model emphasizes customization, with each product and service segment catering to specific health needs. The company’s offerings are structured to address individual health challenges through scientific and personalized approaches. Bioray Biotech Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Bioray Biotech Co stock

Total Assets per Share of Bioray Biotech Co is 17.83 TWD in 2025.

Total Assets per Share of Bioray Biotech Co changed from 18.07 TWD to 17.83 TWD, representing a -1.30% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Total Assets per Share Bioray Biotech Co since 2006 – with annual values, charts, and detailed analysis.

Assets per share divides total assets by shares outstanding, indicating the total resource base backing each share of stock.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Other — Bioray Biotech Co

All Key Metrics — Bioray Biotech Co